Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Greene

Showing results (671-680 of 761) with videos related to

Pageof 77
Sort By:
Breast Cancer Research and Treatment|September 27, 2012
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriersKristen N Stevens, Xianshu Wang, Zachary Fredericksen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening TrialsSteven J Skates, Mark H Greene, Saundra S Buys, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trialsMark D Okusa, Bruce A Molitoris, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settingsBruce A Molitoris, Mark D Okusa, Paul M Palevsky, et al.
Human Molecular Genetics|January 13, 2006
Genome-wide linkage screen for testicular germ cell tumour susceptibility lociGillian P Crockford, Rachel Linger, Sarah Hockley, et al.
Human Molecular Genetics|March 7, 2013
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23Fredrick R Schumacher, Zhaoming Wang, Rolf I Skotheim, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Breast Cancer Research and Treatment|June 5, 2008
No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort studyTimothy R Rebbeck, Antonis C Antoniou, Trinidad Caldes Llopis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor RiskChiara Grasso, Maja Popovic, Elena Isaevska, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Pageof 77

Showing results (671-680 of 761) with videos related to

Sort By:
Pageof 77
Breast Cancer Research and Treatment|September 27, 2012
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriersKristen N Stevens, Xianshu Wang, Zachary Fredericksen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening TrialsSteven J Skates, Mark H Greene, Saundra S Buys, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trialsMark D Okusa, Bruce A Molitoris, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settingsBruce A Molitoris, Mark D Okusa, Paul M Palevsky, et al.
Human Molecular Genetics|January 13, 2006
Genome-wide linkage screen for testicular germ cell tumour susceptibility lociGillian P Crockford, Rachel Linger, Sarah Hockley, et al.
Human Molecular Genetics|March 7, 2013
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23Fredrick R Schumacher, Zhaoming Wang, Rolf I Skotheim, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Breast Cancer Research and Treatment|June 5, 2008
No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort studyTimothy R Rebbeck, Antonis C Antoniou, Trinidad Caldes Llopis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor RiskChiara Grasso, Maja Popovic, Elena Isaevska, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Pageof 77